Ahrens Norbert, Pruss Axel, Kiesewetter Holger, Salama Abdulgabar
Institute for Transfusion Medicine, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany.
Transfus Apher Sci. 2005 Aug;33(1):25-9. doi: 10.1016/j.transci.2005.04.006.
ABO-incompatible red blood cell (RBC) transfusions are a major risk in transfusion medicine. Identification of factors leading to this hazard is important to improve transfusion safety.
All consecutive erroneous ABO-incompatible transfusions occurring from January 1997 to December 2004 at the Charité University Hospital in Berlin, Germany were analysed.
A total of 343,432 RBC units were transfused, and eight patients erroneously received 13 ABO-incompatible RBC concentrates. The most frequent error was incorrect bedside testing (n=7). Intensive care treatment was required in two cases, but there were no fatal mistransfusions. Four patients had no or only mild reactions.
Mistransfusions are still a considerable risk in transfusion medicine despite quality control systems and electronic data processing. An increase in transfusion safety may require the introduction of further systems, e.g. radio-frequency identification (RFID) tags.
ABO血型不相容的红细胞（RBC）输血是输血医学中的一项主要风险。识别导致这种风险的因素对于提高输血安全性至关重要。
分析了1997年1月至2004年12月期间在德国柏林夏里特大学医院发生的所有连续的错误ABO血型不相容输血事件。
共输注了343,432个红细胞单位，8名患者错误地接受了13个ABO血型不相容的红细胞浓缩液。最常见的错误是床边检测错误（n = 7）。2例患者需要重症监护治疗，但没有致命的误输血事件。4例患者没有反应或仅有轻微反应。
尽管有质量控制系统和电子数据处理，误输血在输血医学中仍然是一个相当大的风险。提高输血安全性可能需要引入进一步的系统，例如射频识别（RFID）标签。
